How to Buy Vanda Pharmaceuticals Stock
Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs.
Vanda Pharmaceuticals stock last closed at $4.77, down 0.83% from the previous day, and has increased 23.58% in one year. It has overperformed other stocks in the Biotechnology industry by 1.05 percentage points. Vanda Pharmaceuticals stock is currently +23.26% from its 52-week low of $3.87, and -29.33% from its 52-week high of $6.75.
There are currently 58.32M shares of VNDA outstanding. The market capitalization of VNDA is $278.17M. In the last 24 hours, 666,418 VNDA shares were traded.
How to Buy Vanda Pharmaceuticals Stock
Wondering how to invest in Vanda Pharmaceuticals stock? Here's how.
- Decide where to buy Vanda Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Vanda Pharmaceuticals stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your payment method and add your information.
- Evaluate Vanda Pharmaceuticals stock: The Vanda Pharmaceuticals ticker symbol is VNDA. Is Vanda Pharmaceuticals stock a good investment? Should you buy shares of VNDA? How do VNDA's underlying business fundamentals look? Do top analysts think Vanda Pharmaceuticals is a good buy? Why has VNDA's stock price moved recently? (Hint: Our stock market research tools can help you figure out if VNDA is a good stock to buy).
- Place your VNDA purchase: Decide if you will purchase VNDA shares at the current market price or use a limit order to purchase VNDA stock at a particular price.
- Get the latest news on your investment in VNDA: Create a watchlist to track your investment in Vanda Pharmaceuticals stock.
Step 1: Decide where to buy Vanda Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy VNDA shares.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal information so you are able to buy VNDA stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create a new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on the best stock app, you can securely and quickly fund your account:
Check out the tutorial below to see the process of depositing money into your investment account.
Step 4: Evaluate Vanda Pharmaceuticals stock
Once you have decided on the best place to buy Vanda Pharmaceuticals stock, it's absolutely critical to evaluate their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.
Overview of key VNDA info
Vanda Pharmaceuticals Due Diligence Checks
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on VNDA's stock page.
What is the fair value of VNDA stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge VNDA's intrinsic value.
Using relative valuations methods:
- VNDA could be undervalued based on its P/B ratio of 0.52x, relative to Biotechnology industry P/B ratio of 4.53x
You can access additional valuation research on VNDA's stock here.
How do VNDA Financials look?
Pros:
- VNDA has $374.64M in cash and short term investments. This is enough to cover its annual cash burn of $16.25M.
- VNDA has cash burn of 16247000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the VNDA balance sheet.
- VNDA has a low debt to equity ratio of 0.22.
- There are more short-term assets than long-term liabilities on the VNDA balance sheet.
Cons:
- Total VNDA debt is higher than 5 years ago, relative to shareholder equity.
- VNDA profit margin has gone down from 1.3% to -9.5% in the past year.
Do Wall Street analysts think it's a good time to buy VNDA stock
Out of 1 sell side analysts who give ratings on VNDA, the consensus analyst rating on Vanda Pharmaceuticals is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Vanda Pharmaceuticals stock forecast page.
VNDA Trading Indicators
VNDA Growth Metrics
Last year, VNDA revenue was $198.77M. During the past 5 year, VNDA's revenue has grown by -2.64% per year. This was slower than the Biotechnology industry average of 46.16%.
Dig into VNDA's earnings and revenue performance here.
What are VNDA insiders up to?
Over the last year, executives and large shareholders at VNDA have sold more shares than they have bought.
Mihael Hristos Polymeropoulos, President and CEO of VNDA, was the latest VNDA insider to buy. They bought $25,100.00 worth of VNDA shares on Mar 6, 2025.
Learn more about who owns VNDA shares here.
Can I get consistent income from VNDA stock?
No, Vanda Pharmaceuticals doesn't provide an income stream by paying out dividends.
VNDA Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your VNDA purchase
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Hit the Open Trade button and your broker will place the order.
If you require more help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your investment in VNDA
Now that you own some VNDA shares, you'll want to keep up with your company.
Put VNDA on a watchlist to get notified of the latest news about your VNDA stock.
VNDA Feed
How to Buy Stock in Vanda Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Vanda Pharmaceuticals stock right now:
- Decide where to buy Vanda Pharmaceuticals stock
- Sign up for your brokerage account
- Deposit money your investment account
- Evaluate Vanda Pharmaceuticals stock
- Place your VNDA purchase
- Get the latest news on your investment in VNDA
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Vanda Pharmaceuticals, add VNDA to your watchlist by clicking the button below.
Other Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.